BioCentury
ARTICLE | Company News

Cel-Sci, Johns Hopkins Medical Institutions deal

November 22, 1999 8:00 AM UTC

Johns Hopkins researchers will use HIV's Ligand Epitope Antigen Presentation System ( L.E.A.P.S.) and Antigen Directed Apoptosis (AdapT) technologies to develop an animal model of autoimmune myocardit...